Andrés Henao, MD, FIDSA
@andhen25
ID physician | @UnivalleCol alumnus | Associate Professor @CUAnschutz | Editor-in-Chief @TAInfDis | Associate Editor @PLOSGPH | Global Health | 🇨🇴🇺🇸
ID:3180887052
https://profiles.ucdenver.edu/display/4237911 30-04-2015 19:14:45
4,8K Tweets
1,6K Followers
1,4K Following
Recognition of Infectious Diseases speciality in Spain chng.it/V5DB4TXw vía Change.org España
Dear colleagues and European ID specialists, Spain is the only country without a recognized specialty in Infectious Diseases. Please support us by signing through the QR Piluca Martin-Davila Francesca Gioia Salud Entre Culturas (SEC) Matilde S Conde MICROBIOLOGÍA - Hospital Clínico de Valencia Microbiología Clínica RyC 🧫🔬🦠 PROA_Marañón
Recognition of Infectious Diseases speciality in Spain - ¡Firma la petición! chng.it/2RHw8RXYs6 vía Change.org España
Our article in Lancet Infectious Diseases about Yellow Fever, cited today in this conference at ESCMID Global 2024.
Andrés Henao, MD, FIDSA Daniel Chastain
thelancet.com/journals/lanin…
🤰Exciting News! Introducing our Special Collection on Infections in Pregnancy with Women's Health Journal.Seeking high-quality original research, reviews, meta-analyses, and systematic reviews. Look forward to contributions!
Deadline April 30,2024
bit.ly/48mZKCI
CU Department of Surgery residents took a two-week trip to Vietnam to get an up-close-and-personal look at the emerging field of global medicine. CU Plastic & Reconstructive Surgery
Learn more about the trip here: news.cuanschutz.edu/department-of-…
Epidemiological trends and clinical outcomes of cryptococcosis in a medically insured population in the United States... Daniel B. Chastain, et al. Therapeutic Advances in Infectious Disease. 2024, 11: 1-16. doi.org/10.1177/204993… hdl.handle.net/10045/142343 Jose Tuells
🆕️⚡️Small Observational, retrospective study
Dalbavancin as an alternative to traditional outpatient parenteral antimicrobial therapy for deep gram-positive infections
#DOTS trial soon at #ESCMIDGlobal
AKA #ECCMID2024 #IDXposts journals.sagepub.com/doi/full/10.11…
This study by Priya Nori MD, FSHEA, FIDSA et al assessed feasibility of dalbavancin as for complex gram-positive infections and shows promising results. #Dalbavancin
Read more @ journals.sagepub.com/doi/full/10.11…
🔬Investigating the use of mNGS in non-immunocompromised adult patients with unexplained fever. 🌡️ Found at least one organism in 65.3% of cases, mostly viruses. 💊 Positive clinical impact in 40.3% of cases. Marilyne Daher M. Rizwan Sohail, MD #mNGS journals.sagepub.com/doi/full/10.11…
🦟 Investigating malaria vaccine acceptance in 🇺🇬.432 participants enrolled.💉 91.4% had good acceptance, with factors like knowing a child who died of malaria and preferring injection route associated with acceptance. #MalariaVaccine Okot Jerom
journals.sagepub.com/doi/full/10.11…
Interesting updated epidemiology of #cryptococcosis in a U.S. insured population. Great work by Daniel Chastain and team
CU Infectious Diseases